Showing 21 - 40 results of 1,364 for search '"ligand"', query time: 0.08s Refine Results
  1. 21
  2. 22

    Preparation and Characterization of Cyano Complexes of Oxotungsten(IV) with Mannich Base Ligands by Mohita Sharma, Mohd Saleem, Balgar Singh, H. N. Sheikh, B. L. Kalsotra

    Published 2010-01-01
    “…The complexes have been prepared by the reaction of K3Na [WO2(CN)4].6H2O with morpholinobenzyl urea and related ligands in aqueous solution around pH of 7-8. These have been isolated as bis(triphenylphosphine)iminium or cesium salts. …”
    Get full text
    Article
  3. 23
  4. 24
  5. 25

    Purinergic Receptors of the Central Nervous System: Biology, PET Ligands, and Their Applications by Hamideh Zarrinmayeh PhD, Paul R. Territo PhD

    Published 2020-06-01
    “…Based on their endogenous ligands, purinergic receptors are classified into P1 or adenosine, P2X and P2Y receptors. …”
    Get full text
    Article
  6. 26

    Protonation Equilibria of Biologically Active Ligands in Mixed Aqueous Organic Solvents by Ahmed A. El-Sherif, Mohamed M. Shoukry, Abeer T. Abd Elkarim, Mohammad H. Barakat

    Published 2014-01-01
    “…Equilibrium concentrations of proton-ligand formation as a function of pH were investigated. …”
    Get full text
    Article
  7. 27
  8. 28

    Ligand-Based Pharmacophore Modeling and Virtual Screening of RAD9 Inhibitors by Nirmal K. Prasad, Vishnupriya Kanakaveti, Siddhartha Eadlapalli, Ramakrishna Vadde, Angamba Potshangbam Meetei, Vaibhav Vindal

    Published 2013-01-01
    “…The results revealed that camptothecin can act as an effective inhibitor among all the ligands taken and can be used as an RAD9 inhibitor. …”
    Get full text
    Article
  9. 29

    Structural basis for the ligand-dependent activation of heterodimeric AHR-ARNT complex by Xiaotong Diao, Qinghong Shang, Mengqi Guo, Yubin Huang, Meina Zhang, Xiaoyu Chen, Yinping Liang, Xiangnan Sun, Fan Zhou, Jingjing Zhuang, Shuang-Jiang Liu, Christoph F. A. Vogel, Fraydoon Rastinejad, Dalei Wu

    Published 2025-02-01
    “…Abstract The aryl hydrocarbon receptor (AHR) possesses an extraordinary capacity to sense and respond to a wide range of small-molecule ligands, ranging from polycyclic aromatic hydrocarbons to endogenous compounds. …”
    Get full text
    Article
  10. 30
  11. 31

    Synthesis and Optical Characterization of Mixed Ligands Beryllium Complexes for Display Device Applications by Vandna Nishal, Devender Singh, Raman Kumar Saini, Vijeta Tanwar, Shri Bhagwan, Sonika Kadyan, Ishwar Singh, Pratap Singh Kadyan

    Published 2015-01-01
    “…Synthesis and photoluminescent behaviour of mixed ligand based beryllium complexes with 2-(2-hydroxyphenyl)benzoxazole (HPB) and 5-chloro-8-hydroxyquinoline (Clq) or 5,7-dichloro-8-hydroxyquinoline (Cl2q) or 2-methyl-8-hydroxyquinoline (Meq) or 8-hydroxyquinoline (q) are reported in this work. …”
    Get full text
    Article
  12. 32
  13. 33

    A Peptide Analogue of Selectin Ligands Attenuated Atherosclerosis by Inhibiting Monocyte Activation by Zhishuai Ye, Shanfeng Zhang, Yubo Liu, Shujing Wang, Jianing Zhang, Rongchong Huang

    Published 2019-01-01
    “…Here, we investigated the efficacy of a novel peptide analogue of selectin ligands IELLQAR in atherosclerosis. Methods and Results. …”
    Get full text
    Article
  14. 34

    Association of FAS and FAS Ligand Genes Polymorphism and Risk of Systemic Lupus Erythematosus by Bita Moudi, Saeedeh Salimi, Farzaneh Farajian Mashhadi, Mahnaz Sandoughi, Zahra Zakeri

    Published 2013-01-01
    “…FAS/FASL pathway plays a critical role in maintaining peripheral immune tolerance; therefore, the apoptosis genes, Fas and Fas ligand (FasL), could be suitable candidate genes in human SLE susceptibility. …”
    Get full text
    Article
  15. 35
  16. 36

    The Key to Unlocking the Chemotherapeutic Potential of PPARγ Ligands: Having the Right Combination by Graham Skelhorne-Gross, Christopher J. B. Nicol

    Published 2012-01-01
    “…Despite extensive preclinical evidence that peroxisome proliferator-activated receptor (PPAR)γ activation protects against tumourigenesis, results from a few clinical trials using PPARγ ligands as monotherapy show modest success. In spite of this, several groups reported exciting results with therapeutic regimens that combine PPARγ ligands with other compounds: chemotherapeutic agents, retinoid x receptor (RXR)α agonists, statins, or cell-to-cell signaling molecules in preclinical cancer models and human trials. …”
    Get full text
    Article
  17. 37
  18. 38
  19. 39

    CTLA-4 and PD-1 Ligand Gene Expression in Epithelial Thyroid Cancers by Chiara Tuccilli, Enke Baldini, Salvatore Sorrenti, Antonio Catania, Alessandro Antonelli, Poupak Fallahi, Francesco Tartaglia, Susi Barollo, Caterina Mian, Andrea Palmieri, Giovanni Carbotta, Stefano Arcieri, Daniele Pironi, Massimo Vergine, Massimo Monti, Salvatore Ulisse

    Published 2018-01-01
    “…The dysregulation of PD-1 ligands (PD-L1 and PD-L2) and CTLA-4 ligands (CD80 and CD86) represents a tumor strategy to escape the immune surveillance. …”
    Get full text
    Article
  20. 40

    Emerging PPARγ-Independent Role of PPARγ Ligands in Lung Diseases by Ajit A. Kulkarni, Collynn F. Woeller, Thomas H. Thatcher, Sesquile Ramon, Richard P. Phipps, Patricia J. Sime

    Published 2012-01-01
    “…These ligands modulate multiple cellular pathways via both PPARγ-dependent and PPARγ-independent mechanisms. …”
    Get full text
    Article